Screening for Cognitive Impairment in Older Adults - Bookswagon
Screening for Cognitive Impairment in Older Adults

Screening for Cognitive Impairment in Older Adults


     0     
5
4
3
2
1



International Edition


About the Book

Dementia is an acquired condition that is characterized by a decline in at least two cognitive domains (e.g., loss of memory, attention, language, or visuospatial or executive functioning) that is severe enough to affect social or occupational functioning. Patients with dementia may also exhibit behavioral and psychological symptoms. The proposed Diagnostic and Statistical Manual, version 5 (DSM-V) subsumes dementia under a new syndrome, "major neurocognitive disorder." Patients with major neurocognitive disorder experience a significant cognitive decline that is significant enough to interfere with independence in instrumental activities of daily living (IADLs), but this decline cannot be wholly due to delirium or another mental disorder, such as schizophrenia. Based on its etiology, dementia can be classified as degenerative, vascular, or other. The major dementia syndromes in older adults include: Alzheimer's disease, vascular dementia, frontotemporal dementia, dementia with Lewy bodies, Parkinson's disease with dementia, and dementia of mixed etiology. In these dementia syndromes, abnormal deposits that accumulate in the brain are believed to contribute to deterioration of brain function and dementia. The exact etiological mechanisms for many types of dementia, however, have not been clearly defined. Mild Cognitive Impairment (MCI) is distinguished from dementia in that cognitive impairment is not severe enough to interfere with independence in daily life. Researchers describe this condition using various terminology that includes differences in diagnostic criteria and underlying constructs, such as MCI, cognitive impairment no dementia, age-related cognitive decline, mild neurocognitive disorder, and mild cognitive disorder. The International Working Group on Mild Cognitive Impairment established the current, and perhaps most commonly used, criteria for MCI as: cognitive decline as evidenced by self and/or informant and/or clinician report and impairment on objective cognitive tasks, and/or evidence of decline over time on objective tasks; preserved basic activities of daily living (ADLs) (or minimal impairment in complex instrumental functions); and does not meet DSM-IV, ICD-10 criteria for a dementia syndrome. MCI is thought to be an intermediate phase between normal cognition and dementia. In 2003, the USPSTF concluded that there was insufficient evidence to recommend for or against routine screening for dementia in older adults (I statement). This recommendation was based on an evidence review that indicated that while some screening tests had good sensitivity, they had only fair specificity in detecting cognitive impairment and dementia. While this review found evidence that several drug therapies had a beneficial effect on cognitive function, the magnitude of this benefit was small. In 2011, we developed a work plan for this evidence review to address the previous review's evidence gaps and support the USPSTF in updating its previous recommendation. This updated recommendation is focused more broadly on screening for cognitive impairment, including both dementia and mild cognitive impairment (MCI). This evidence review was designed to assess 1) the net benefit and diagnostic accuracy of brief screening instruments to detect cognitive impairment in older adults, and 2) the net benefit of the commonly used treatment and management options for older adults with MCI or early dementia and their caregivers. Our review primarily focuses on screening adults in primary care, rather than specialty care settings (e.g., neurology or memory clinics), and the management of screen-detected people with cognitive impairment, excluding delirium. As a result, this review includes the treatment and management of people with MCI and mild to moderate dementia, as opposed to moderately-severe or severe dementia.


Best Sellers



Product Details
  • ISBN-13: 9781495302527
  • Publisher: Createspace Independent Publishing Platform
  • Publisher Imprint: Createspace Independent Publishing Platform
  • Height: 279 mm
  • No of Pages: 412
  • Series Title: English
  • Sub Title: An Evidence Update for the U.S. Preventive Services Task Force: Evidence Synthesis Number 107
  • Width: 216 mm
  • ISBN-10: 1495302520
  • Publisher Date: 23 Jan 2014
  • Binding: Paperback
  • Language: English
  • Returnable: N
  • Spine Width: 21 mm
  • Weight: 997 gr


Add Photo
Add Photo

Customer Reviews

REVIEWS      0     
Click Here To Be The First to Review this Product
Screening for Cognitive Impairment in Older Adults
Createspace Independent Publishing Platform -
Screening for Cognitive Impairment in Older Adults
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Screening for Cognitive Impairment in Older Adults

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    New Arrivals



    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!